Metabolism and functions of glutathione in brain

Progress in Neurobiology

Volumn 62, Issue 6, 2000, Pages 649-671

  Dringen, Ralf ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; GLUTATHIONE; PEROXIDE; REACTIVE OXYGEN METABOLITE; THIOL DERIVATIVE;

ASTROCYTE; BRAIN; BRAIN CELL; BRAIN NERVE CELL; CELL CULTURE; CELL INTERACTION; CELL TYPE; COCULTURE; GLIA CELL; GLUTATHIONE METABOLISM; HOST RESISTANCE; HUMAN; MICROGLIA; NEUROLOGIC DISEASE; NONHUMAN; OLIGODENDROGLIA; OXIDATION; OXYGEN CONSUMPTION; PRIORITY JOURNAL; REVIEW;

ANIMALS; ASTROCYTES; BIOLOGICAL TRANSPORT; BRAIN; CELL COMMUNICATION; CELLS, CULTURED; EXTRACELLULAR SPACE; GLUTATHIONE; HUMANS; MICROGLIA; NEURODEGENERATIVE DISEASES; NEURONS; OLIGODENDROGLIA; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES;

EID: 0034672943     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0082(99)00060-X     Document Type: Review

References (303)

1. Abe K., Saito H. Characterization of t-butyl hydroperoxide toxicity in cultured rat cortical neurones and astrocytes. Pharmacol. Toxicol. 83:1998;40-46.
2. Abramovitz M., Homma H., Ishigaki S., Tansey F., Cammer W., Listowsky I. Characterization and localization of glutathione-S-transferases in rat brain and binding of hormones, neurotransmitters, and drugs. J. Neurochem. 50:1988;50-57.
3. Acan N.L., Tezcan E.F. Sheep brain glutathione reductase: purification and general properties. FEBS. Lett. 250:1989;72-74.
4. Acan N.L., Tezcan E.F. Kinetic properties of sheep brain glutathione reductase. Enzymes. 45:1991;121-124.
5. Acan N.L., Tezcan E.F. Inhibition kinetics of sheep brain glutathione reductase by cadmium ion. Biochem. Mol. Med. 54:1995;33-37.
6. Akerboom T., Sies H. Glutathione transport and its significance in oxidative stress. Vina J. Glutathione: Metabolism and Physiological Functions. 1990;45-55 CRC Press, Boca Raton, FL, USA.
7. Almeida A., Heales S.J.R., Bolanos J.P., Medina J.M. Glutamate neurotoxicity is associated with nitric oxide-mediated mitochondrial dysfunction and glutathione depletion. Brain Res. 790:1998;209-216.
8. Amara A., Coussemarcq M., Geffard M. Antibodies to reduced glutathione. Brain Res. 659:1994;237-242.
9. Ambani L.M., van Woert M.H., Murphy S. Brain peroxidase and catalase in Parkinson disease. Arch. Neurol. 32:1975;114-118.
10. Andersen J.K., Mo J.Q., Hom D.G., Lee F.Y., Harnish P., Hamill R.W., McNeill T.H. Effect of buthionine sulfoximine, a synthesis inhibitor of the antioxidant glutathione, on the murine nigrostriatal neurons. J. Neurochem. 67:1996;2164-2171.
11. Anderson M.E., Meister A. Transport and direct utilization of γ-glutamylcyst(e)ine for glutathione synthesis. Proc. Natl. Acad. Sci. USA. 80:1983;707-711.
12. Anderson M.E., Underwood M., Bridges R.J., Meister A. Glutathione metabolism at the blood-cerebrospinal fluid barrier. FASEB J. 3:1989;2527-2531.
13. Arteel G.E., Briviba K., Sies H. Protection against peroxynitrite. FEBS Lett. 445:1999;226-230.
14. Aschner M. The functional significance of brain metallothioneins. FASEB J. 10:1996;1129-1136.
15. Aschner M., Mullaney K.J., Wagoner D., Lash L.H., Kimmelberg H.K. Intracellular glutathione (GSH) levels modulate mercuric chloride (MC)- and methylmercuric chloride (MeHgCl)-induced amino acid release from neonatal rat primary astrocytes cultures. Brain Res. 664:1994;133-140.
16. Aschner M., Allen J.W., Kimmelberg H.K., LoPachin R.M., Streit W.J. Glial cells in neurotoxicity development. Annu. Rev. Pharmacol. Toxicol. 39:1999;151-173.
17. Aw T.Y., Ookhtens M., Kaplowitz N. Inhibition of glutathione efflux from isolated rat hepatocytes by methionine. J. Biol. Chem. 259:1984;9355-9358.
18. Aw T.Y., Ookhtens M., Ren C., Kaplowitz N. Kinetics of glutathione efflux from isolated rat hepatocytes. Am. J. Physiol. 250:1986;G236-G243.
19. Awasthi Y.C., Sharma R., Singhal S.S. Human glutathione S-transferases. Int. J. Biochem. 26:1994;295-308.
20. Back S.A., Gan X., Li Y., Rosenberg P.A., Volpe J.J. Maturation-dependent vulnerability of oligodendrocytes to oxidative stress-induced death caused by glutathione depletion. J. Neurosci. 18:1998;6241-6253.
21. Bains J.S., Shaw C.A. Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death. Brain Res. Rev. 25:1997;335-358.
22. Barker J.E., Bolanos J.P., Land J.M., Clark J.B., Heales S.J.R. Glutathione protects astrocytes from peroxynitrite-mediated mitochondrial damage: implications for neuronal/astrocytic trafficking and neurodegeneration. Dev. Neurosci. 18:1996;391-396.
23. Beckman K.B., Ames B.N. The free radical theory of aging matures. Physiol. Rev. 78:1998;547-581.
24. Behl C. Alzheimer's disease and oxidative stress: implications for novel therapeutic approaches. Prog. Neurobiol. 57:1999;301-323.
25. Bensadoun J.C., Mirochnitchenko O., Inouye M., Aebischer P., Zurn A.D. Attenuation of 6-OHDA-induced neurotoxicity in glutathione peroxidase transgenic mice. Eur. J. Neurosci. 10:1998;3231-3236.
26. Benuck M., Banay-Schwartz M., DeGuzman T., Lajtha A. Effect of food deprivation on glutathione and amino acid levels in brain and liver of young and aged rats. Brain Res. 678:1995;259-264.
27. Ben-Yoseph O., Boxer P.A., Ross B.D. Oxidative stress in the central nervous system: monitoring the metabolic response using the pentose phosphate pathway. Dev. Neurosci. 16:1994;328-336.
28. Ben-Yoseph O., Boxer P.A., Ross B.D. Assessment of the role of the glutathione and pentose phosphate pathways in the protection of primary cerebrocortical cultures from oxidative stress. J. Neurochem. 66:1996;2329-2337.
29. Bezard E., Gross C.E., Fournier M.C., Dovero S., Bloch B., Jaber M. Absence of MPTP-induced neuronal death in mice lacking the dopamine transporter. Exp. Neurol. 155:1999;268-273.
30. Benzi G., Moretti A. Age- and peroxidative stress-related modifications of the cerebral enzymatic activities linked to mitochondria and the glutathione system. Free Radical Biol. Med. 19:1995;77-101.
31. Berry M.D., Juorio A.V., Paterson I.A. The functional role of monoamine oxidases A and B in the mammalian central nervous system. Prog. Neurobiol. 42:1994;375-391.
32. 2+ homeostasis and cell death. J. Neurochem. 70:1998;958-970.
33. Bolanos J.P., Heales S.J.R., Land J.M., Clark J.B. Effect of peroxynitrite on the mitochondrial respiratory chain: differential susceptibility of neurones and astrocytes in primary culture. J. Neurochem. 64:1995;1965-1972.
34. Bolanos J.P., Heales S.J.R., Peuchen S., Barker J.E., Land J.M., Clark J.B. Nitric oxide-mediated mitochondrial damage: a potential neuroprotective role for glutathione. Free Radical Biol. Med. 21:1996;995-1001.
35. Bronstein D.M., Perez-Otano I., Sun V., Mullis Sawin S.B., Chan J., Wu G.-C., Hudson P.M., Kong L.-Y., Hong J.-S., McMillan M.K. Glia-dependent neurotoxicity and neuroprotection in mesencephalic cultures. Brain Res. 704:1995;112-116.
36. Browne S.E., Ferrante R.J., Beal M.F. Oxidative stress in Huntington's disease. Brain Pathol. 9:1999;147-163.
37. Cadet J.L., Brannock C. Free radicals and the pathobiology of brain dopamine systems. Neurochem. Int. 32:1998;117-131.
38. Cassarino D.S., Bennet J.P. Jr. An evaluation of the role of mitochondria in neurodegenerative diseases: mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration. Brain Res. Rev. 29:1999;1-25.
39. b subunits in oligodendrocytes and astrocytes of rat brain. J. Neurochem. 52:1989;876-883.
40. Chance B., Sies H., Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol. Rev. 59:1979;527-605.
41. Chao C.C., Lee E.H.Y. Neuroprotective mechanism of glial cell line-derived neurotrophic factor on dopamine neurons: role of antioxidation. Neuropharmacology. 38:1999;913-916.
42. Chao C.C., Hu S., Peterson P.K. Glia: the not so innocent bystanders. J. Neurovirol. 2:1996;234-239.
43. Chatterjee S., Noack H., Possel H., Keilhoff G., Wolf G. Glutathione levels in primary glial cultures: monochlorobimane provides evidence of cell type specific distribution. Glia. 27:1999;152-161.
44. Cheng B., Mattson M.P. PDGFs protect hippocampal neurons against energy deprivation and oxidative injury: evidence for induction of antioxidant pathways. J. Neurosci. 15:1995;7095-7104.
45. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1:1988;623-634.
46. Clancy R.M., Levartovsky D., Leszcynska-Piziak J., Yegudin J., Abramson S.B. Nitric oxide reacts with intracellular glutathione and activates the hexose monophosphate shunt in human neutrophils: evidence for S-nitrosoglutathione as a bioactive intermediate. Proc. Natl. Acad. Sci. USA. 91:1994;3680-3684.
47. Clarke D.D., Sokoloff L. Circulation and energy metabolism of the brain. Sigel G.J., Agranoff B.W., Albers R.W., Fisher S.K., Uhler M.D. Basic Neurochemistry: Molecular, Cellular and Medical Aspects. 1999;637-669 Lippincott-Raven, Philadelphia.
48. Colton C.A., Gilbert D.L. Production of superoxide anions by a CNS macrophage, the microglia. FEBS Lett. 223:1987;284-288.
49. Commandeur J.N.M., Stijntjes G.J., Vermeulen N.P.E. Enzymes and transport systems involved in the formation and disposition of glutathione S-conjugates. Pharmacol. Rev. 47:1995;271-330.
50. Cookson M.R., Shaw P.J. Oxidative stress and motor neuron disease. Brain Pathol. 9:1999;165-186.
51. Cooper A.J.L. Glutathione in the brain: disorders of glutathione metabolism. Rosenberg R.N., Prusiner S.B., DiMauro S., Barchi R.L., Kunk L.M. The Molecular and Genetic Basis of Neurological Disease. 1997;1195-1230 Butterworth-Heinemann, Boston.
52. Cooper A.J.L. Role of astrocytes in maintaining cerebral glutathione homeostasis and in protecting the brain against xenobiotics and oxidative stress. Shaw C.A. The Role of Glutathione in the Nervous System. 1998;91-115 Taylor and Francis, Washington.
53. Cooper A.J.L., Kristal B.S. Multiple roles of glutathione in the central nervous system. Biol. Chem. 378:1997;793-802.
54. Cotgreave I.A., Gerdes R.G. Recent trends in glutathione biochemistry - glutathione-protein interactions: a molecular link between oxidative stress and cell proliferation? Biochem. Biophys. Res. Commun. 242:1998;1-9.
55. Damier P., Hirsch E.C., Zhang P., Agid Y., Javoy-Agid F. Glutathione peroxidase, glial cells and Parkinson's disease. Neuroscience. 52:1993;1-6.
56. de Haan J.B., Bladier C., Griffiths P., Kelner M., O'Shea R.D., Cheung N.S., Bronson R.T., Silvestro M.J., Wild S., Zheng S.S., Beart P.M., Hertzog P.J., Kola I. Mice with a homozygous null mutation for the most abundant glutathione peroxidase, Gpx1, show increased susceptibility to the oxidative stress-inducing agents paraquat and hydrogen peroxide. J. Biol. Chem. 273:1998;22528-22536.
57. Deneke S.M., Susanto I., Vogel K.A., Williams C.E., Lawrence R.A. Mechanism of use of extracellular glutathione by lung epithelial cells and pulmonary artery endothelial cells. Am. J. Respir. Cell Mol. Biol. 12:1995;662-668.
58. Desagher S., Glowinski J., Premont J. Astrocytes protect neurons from hydrogen peroxide toxicity. J. Neurosci. 16:1996;2553-2562.
59. Desagher S., Glowinski J., Premont J. Pyruvate protects neurons against hydrogen peroxide-induced toxicity. J. Neurosci. 17:1997;9060-9067.
60. de Saint Vincent B.R., Mousset S., Jacquemin-Sablon A. Cysteine control over glutathione homeostasis in Chinese hamster fibroblasts overexpressing a γ-glutamylcysteine synthetase activity. Eur. J. Biochem. 262:1999;873-878.
61. Devesa A., O'Connor J.E., Garcia C., Puertes I.R., Vina J.R. Glutathione metabolism in primary astrocyte culture: flow cytometric evidence for heterogeneous distribution of GSH content. Brain Res. 618:1993;181-189.
62. Dexter D.T., Sian J., Rose S., Hindmarsh J.G., Mann V.M., Cooper J.M., Wells F.R., Daniel S.E., Lees A.J., Schapira A.H., Jenner P., Marsden C.D. Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease. Ann. Neurol. 35:1994;38-44.
63. Di Mascio P., Murphy M.E., Sies H. Antioxidant defense systems: the role of carotinoids, tocopherols, and thiols. Am. J. Clin. Nutr. 53:1991;194S-200S.
64. Dringen R., Hamprecht B. Glutathione content as an indicator for the presence of metabolic pathways of amino acids in astroglial cultures. J. Neurochem. 67:1996;1375-1382.
65. Dringen R., Hamprecht B. Involvement of glutathione peroxidase and catalase in the disposal of exogenous hydrogen peroxide by cultured astroglial cells. Brain Res. 759:1997;67-75.
66. Dringen R., Hamprecht B. Glutathione restoration as indicator for cellular metabolism of astroglial cells. Dev. Neurosci. 20:1998;401-407.
67. Dringen R., Hamprecht B. N-Acetylcysteine, but not methionine or 2-oxothiazolidine-4-carboxylate, serves as cysteine donor for the synthesis of glutathione in cultured neurons derived from embryonal rat brain. Neurosci. Lett. 259:1999;79-82.
68. Dringen R., Kranich O., Hamprecht B. The γ-glutamyl transpeptidase inhibitor acivicin preserves glutathione released by astroglial cells in culture. Neurochem. Res. 22:1997;727-733.
69. Dringen R., Kranich O., Löschmann P.A., Hamprecht B. Use of dipeptides for the synthesis of glutathione by astroglia-rich primary cultures. J. Neurochem. 69:1997;868-874.
70. Dringen R., Kussmaul L., Hamprecht B. Rapid clearance of tertiary butyl hydroperoxide by cultured astroglial cells via oxidation of glutathione. Glia. 23:1998;139-145.
71. Dringen R., Kussmaul L., Hamprecht B. Detoxification of exogenous hydrogen peroxide and organic hydroperoxides by cultured astroglial cells assessed by a microtiter plate assay. Brain Res. Protoc. 2:1998;223-228.
72. Dringen R., Verleysdonk S., Hamprecht B., Willker W., Leibfritz D., Brand A. Metabolism of glycine in primary astroglial cells: synthesis of creatine, serine, and glutathione. J. Neurochem. 70:1998;835-840.
73. Dringen R., Hamprecht B., Bröer S. The peptide transporter PepT2 mediates the uptake of the glutathione precursor CysGly in astroglia-rich primary cultures. J. Neurochem. 71:1998;388-393.
74. Dringen R., Hamprecht B., Drukarch B. Anethole dithiolethione, a putative neuroprotectant, increases intracellular and extracellular glutathione levels during starvation of cultured astroglial cells. Naunyn-Schmiedeb. Arch. Pharmacol. 358:1998;616-622.
75. Dringen R., Pfeiffer B., Hamprecht B. Synthesis of the antioxidant glutathione in neurons: supply by astrocytes of CysGly as precursor for neuronal glutathione. J. Neurosci. 19:1999;562-569.
76. Dringen R., Kussmaul L., Gutterer J.M., Hirrlinger J., Hamprecht B. The glutathione system of peroxide detoxification is less efficient in neurons than in astroglial cells. J. Neurochem. 72:1999;2523-2530.
77. Drukarch B., Schepens E., Stoof J.C., Langeveld C.H. Anethole dithiolethione prevents oxidative damage in glutathione depleted astrocytes. Eur. J. Pharmacol. 329:1997;259-262.
78. Drukarch B., Schepens E., Jongenelen C.A.M., Stoof J.C., Langeveld C.H. Astrocyte-mediated enhancement of neuronal survival is abolished by glutathione deficiency. Brain Res. 770:1997;123-130.
79. Drukarch B., Schepens E., Stoof J.C., Langeveld C.H., van Muiswinkel F.L. Astrocyte-enhanced neuronal survival is mediated by scavenging of extracellular reactive oxygen species. Free Radical Biol. Med. 25:1998;217-220.
80. Dunnet S.B., Björklund A. Prospects for new restorative and neuroprotective treatments in Parkinson's disease. Nature. 399:1999;A32-A39.
81. Ennis S.R., Kawai N., Ren X.D., Abdelkarim G.E., Keep R.F. Glutamine uptake at the blood-brain barrier is mediated by N-system transport. J. Neurochem. 71:1998;2565-2573.
82. Facchinetti F., Dawson V.L., Dawson T.M. Free radicals as mediators in neuronal injury. Cell. Mol. Neurobiol. 18:1998;667-682.
83. Favilli F., Marraccini P., Iantomasi T., Vincenzini M.T. Effect of orally administered glutathione on glutathione levels in some organs of rats: role of specific transporters. Br. J. Nutr. 78:1997;293-300.
84. Frey A. Gamma-glutamyl transpeptidase: molecular cloning and structural and functional features of a blood-brain barrier marker protein. Pardridge W.M. The Blood-Brain Barrier. 1993;339-368 Raven Press, New York.
85. Frey A., Meckelein B., Weiler-Güttler H., Möckel B., Flach R., Gassen H.G. Pericytes of the brain microvasculature express γ-glutamyl transpeptidase. Eur. J. Biochem. 202:1991;421-429.
86. Fridovich I. Superoxide radical and superoxide dismutases. Annu. Rev. Biochem. 64:1995;97-112.
87. Garcia-Nogales P., Almeida A., Fernandez E., Medina J.M., Bolanos J.P. Induction of glucose-6-phosphate dehydrogenase by lipopolysaccharide contributes to preventing nitric oxide-mediated glutathione depletion in cultured rat astrocytes. J. Neurochem. 72:1999;1750-1758.
88. 3 regulates γ-glutamyl transpeptidase activity in rat brain. Neurosci. Lett. 216:1996;183-186.
89. 3 regulates the synthesis of γ-glutamyl transpeptidase and glutathione levels in rat primary astrocytes. J. Neurochem. 73:1999;859-866.
90. Gash D.M., Zhang Z., Gerhardt G. Neuroprotective and neurorestorative properties of GDNF. Ann. Neurol. 44:(1):1998;S121-S125.
91. Gate L., Paul L., Nguyen Ba G., Tew K.D., Tapiero H. Oxidative stress induced pathologies: the role of antioxidants. Biomed. Pharmacother. 53:1999;169-180.
92. Gerlach M., Ben-Shachar D., Riederer P., Youdim M.B.H. Altered brain metabolism of iron as a cause of neurodegenerative diseases? J. Neurochem. 63:1994;793-807.
93. Ghandour M.S., Langley O.K., Varga V. Immunohistological localization of γ-glutamyltranspeptidase in cerebellum at light and electron microscope levels. Neurosci. Lett. 20:1980;125-129.
94. Ghibelli L., Fanelli C., Rotilio G., Lafavia E., Coppola S., Colussi C., Civitareale P., Ciriolo M.R. Rescue of cells from apoptosis by inhibition of active GSH extrusion. FASEB J. 12:1998;479-486.
95. Ghyselinck N.B., Dufaure I., Lareyre J.J., Rigaudiere N., Mattei M.G., Dufaure J.P. Structural organization and regulation of the gene for the androgen-dependent glutathione peroxidase-like protein specific to the mouse epididymis. Mol. Endocrinol. 7:1993;258-272.
96. Gong L., Wyatt R.J., Baker I., Masserano J.M. Brain-derived and glial cell line-derived neurotrophic factors protect a catecholaminergic cell line from dopamine-induced cell death. Neurosci. Lett. 263:1999;153-156.
97. Grasbon-Frodl E.M., Andersson A., Brundin P. Lazaroid treatment prevents death of cultured rat embryonic mesencephalic neurons following glutathione depletion. J. Neurochem. 67:1996;1653-1660.
98. Guo N., McIntosh C., Shaw C. Glutathione: new candidate neuropeptide in the central nervous system. Neuroscience. 51:1992;835-842.
99. Gutterer, J.M., Dringen, R., Hirrlinger, J., Hamprecht, B., 1999. Purification of glutathione reductase from bovine brain, generation of an antiserum and immunocytochemical localization of the enzyme in neural cells. J. Neurochem. 73, 1422-1430.
100. Hall A.G. The role of glutathione in the regulation of apoptosis. Eur. J. Clin. Invest. 29:1999;238-245.
101. Halliwell B. Reactive oxygen species and the central nervous system. J. Neurochem. 59:1992;1609-1623.
102. Halliwell B., Gutteridge J.M.C. Free Radicals in Biology and Medicine. 1999;Oxford University Press, New York.
103. Han S.K., Mytilineou C., Cohen G. L-DOPA up-regulates glutathione and protects mesencephalic cultures against oxidative stress. J. Neurochem. 66:1996;501-510.
104. Heales S.J.R., Bolanos J.P., Stewart V.C., Brookes P.S., Land J.M., Clark J.B. Nitric oxide, mitochondria and neurological disease. Biochim. Biophys. Acta. 1410:1999;215-228.
105. Hertz L., Dringen R., Schousboe A., Robinson S.R. Astrocytes: glutamate producers for neurons. J. Neurosci. Res. 57:1999;417-428.
106. Hille R., Nishino T. Flavoprotein structure and mechanism. Part IV: xanthine oxidase and xanthine dehydrogenase. FASEB J. 9:1995;995-1003.
107. Hirrlinger J., Gutterer J.M., Kussmaul L., Hamprecht B., Dringen R. Microglial cells in culture express a prominent glutathione system for the detoxification of reactive oxygen species. J. Neurochem. 73:1999;S77C.
108. Hirrlinger, J., Gutterer, J.M., Kussmaul, L., Hamprecht, B., Dringen, R., 2000. Microglial cells in culture express a prominent glutathione system for the defense against reactive oxygen species. Dev. Neurosci., in press.
109. Hirsch E.C., Faucheux B.A. Iron metabolism and Parkinson's disease. Mov. Disord. 13:(1):1998;39-45.
110. Hirsch E.C., Hunot S., Damier P., Faucheux B. Glial cells and inflamation in Parkinson's disease: a role in neurodegeneration? Ann. Neurol. 44:(1):1998;S115-S120.
111. Hjelle O.P., Chaudhry A.C., Ottersen O.P. Antisera to glutathione: characterization and immunocytochemical application to the rat cerebellum. Eur. J. Neurosci. 6:1994;793-804.
112. Ho Y.S., Magnenat J.L., Bronson R.T., Cao J., Gargano M., Sugawara M., Funk C.D. Mice deficient in cellular glutathione peroxidase develop normally and show no increased sensitivity to hyperoxia. J. Biol. Chem. 272:1997;16644-16651.
113. Hochman A., Sternin H., Gorodin S., Korsmeyer S., Ziv I., Melamed E., Offen D. Enhanced oxidative stress and altered antioxidants in brains of Bcl-2-deficient mice. J. Neurochem. 71:1998;741-748.
114. Hou J.G.G., Cohen G., Mytilineou C. Basic fibroblast growth factor stimulation of glial cells protects dopamine neurons from 6-hydroxydopamine toxicity: involvement of the glutathione system. J. Neurochem. 69:1997;76-83.
115. Hoyt K.R., Gallagher A.J., Hastings T.G., Reynolds I.J. Characterization of hydrogen peroxide toxicity in cultured rat forebrain neurons. Neurochem. Res. 22:1997;333-340.
116. Huang J., Philbert M.A. Distribution of glutathione and glutathione-related enzyme systems in mitochondria and cytosol of cultured cerebellar astrocytes and granule cells. Brain Res. 680:1995;16-22.
117. Huang J., Philbert M.A. Cellular responses of cultured cerebellar astrocytes to ethacrynic acid-induced perturbation of subcellular glutathione homeostasis. Brain Res. 711:1996;184-192.
118. 4 as a mediator of luteinizing hormone release from rat anterior pituitary cells. Proc. Natl. Acad. Sci. USA. 82:1985;3834-3838.
119. Husain J., Juurlink B.H.J. Oligodendroglial precursor cell susceptibility to hypoxia is related to poor ability to cope with reactive oxygen species. Brain Res. 698:1995;86-94.
120. Iwata-Ichikawa E., Kondo Y., Miyazaki I., Asanuma M., Ogawa N. Glial cells protect neurons against oxidative stress via transcriptional up-regulation of the glutathione synthesis. J. Neurochem. 72:1999;2334-2344.
121. Jackson G.R., Werrbach-Perez K., Pan Z., Sampath D., Perez-Polo J.R. Neurotrophin regulation of energy homeostasis in the central nervous system. Dev. Neurosci. 16:1994;285-290.
122. Jacob R.A. The integrated antioxidant system. Nutr. Res. 15:1995;755-766.
123. Jäger M., Weber P., Wolf S. Immunohistochemical localization of 5-oxo-L-prolinase, an enzyme of the γ-glutamyl cycle, in porcine brain microvessels. FEBS Lett. 445:1999;215-217.
124. Jain A., Martensson J., Stole E., Auld P.A.M., Meister A. Glutathione deficiency leads to mitochondrial damage in brain. Proc. Natl. Acad. Sci. USA. 88:1991;1913-1917.
125. Janaky R., Ogita K., Pasqualotto B.A., Bains J.S., Oja S.S., Yondea Y., Shaw C.A. Glutathione and signal transduction in the mammalian CNS. J. Neurochem. 73:1999;889-902.
126. Jellinger K.A. The role of iron in neurodegeneration - prospects for pharmacotherapie of Parkinson's disease. Drugs Aging. 14:1999;115-140.
127. Jenner P. Oxidative mechanisms in nigral cell death in Parkinson's disease. Mov. Disord. 13:(1):1998;24-34.
128. Jenner P., Olanow C.W. Understanding cell death in Parkinson's disease. Ann. Neurol. 44:(1):1998;S72-S84.
129. Jenner P., Dexter D.T., Sian J., Schapira A.H., Marsden C.D. Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. Ann. Neurol. 32:1992;S82-S87.
130. Johnson J.A., Barbary A.E., Kornguth S.E., Brugge J.F., Siegel F.L. Glutathione S-transferase isoenzymes in rat brain neurons and glia. J. Neurosci. 13:1993;2013-2023.
131. Juurlink B.H.J. NADP-linked isozymes are the major forms of isocitrate dehydrogenase in mouse type-1-like astrocytes. Life Sci. 52:1993;1087-1090.
132. Juurlink B.H.J. Response of glial cells to ischemia: roles of reactive oxygen species and glutathione. Neurosci. Biobehav. Rev. 21:1997;151-166.
133. Juurlink B.H.J., Schültke E., Hertz L. Glutathione release and catabolism during energy substrate restriction in astrocytes. Brain Res. 710:1996;229-233.
134. Juurlink B.H.J., Thornburne S.K., Hertz L. Peroxide-scavenging deficit underlies oligodendrocyte susceptibility to oxidative stress. Glia. 22:1998;371-378.
135. Kakimoto Y., Nakajima T., Kanazawa A., Takesada M., Sano I. Isolation of γ-L-glutamyl-L-glutamic acid and γ-L-glutamyl-L-glutamine from bovine brain. Biochim. Biophys. Acta. 93:1964;333-338.
136. Kanazawa A., Kakimoto Y., Nakajima T., Sano I. Identification of γ-glutamylserine, γ-glutamylalanine, γ-glutamylvaline and S-methylglutathione of bovine brain. Biochim. Biophys. Acta. 111:1965;90-95.
137. Kannan R., Kuhlenkamp J.F., Jeandidier E., Trinh H., Ookhtens M., Kaplowitz N. Evidence for carrier-mediated transport of glutathione across the blood-brain barrier in the rat. J. Clin. Invest. 85:1990;2009-2013.
138. Kannan R., Kuhlenkamp J.F., Ookhtens M., Kaplowitz N. Transport of glutathione at blood-brain barrier of the rat: inhibition by glutathione analogs and age-dependence. J. Pharmacol. Exp. Ther. 263:1992;964-970.
139. Kannan R., Yi J.R., Tang D., Li Y., Zlokovic B.V., Kaplowitz N. Evidence for the existence of a sodium-dependent glutathione (GSH) transporter. J. Biol. Chem. 271:1996;9754-9758.
140. Kannan R., Mittur A., Bao Y., Tsuruo T., Kaplowitz N. GSH transport in immortalized mouse brain endothelial cells: evidence for apical localization of a sodium-dependent GSH transporter. J. Neurochem. 73:1999;390-399.
141. Kaplowitz N., Fernandez-Checa J.C., Kannan R., Garcia-Ruiz C., Ookhtens M., Yi J.R. GSH transporters: molecular characterization and role in GSH homeostasis. Biol. Chem. Hoppe-Seyler. 377:1996;267-273.
142. Kim Y.S., Kim S.U. Oligodendroglia cell death induced by oxygen radicals and its protection by catalase. J. Neurosci. Res. 29:1991;100-106.
143. Kim-Han J.S., Sun A.Y. Protection of PC12 cells by glutathione peroxidase in L-DOPA induced cytotoxicity. Free Radical Biol. Med. 25:1998;512-518.
144. Kish S.J., Morito C., Hornykiewicz O. Glutathione peroxidase activity in Parkinson's disease. Neurosci. Lett. 58:1985;343-346.
145. Knollema S., Hom H.W., Schirmer H., Korf J., Ter Horst G.J. Immunolocalization of glutathione reductase in the murine brain. J. Comp. Neurol. 373:1996;157-172.
146. Kojima S., Matsuki O., Nomura T., Shimura N., Kubodera A., Yamaoka K., Tanooka H., Wakasugi H., Honda Y., Honda S., Sasaki T. Localization of glutathione and induction of glutathione synthesis-related proteins in mouse brain by low doses of γ-rays. Brain Res. 808:1998;262-269.
147. Kösel S., Hofhaus G., Maassen A., Vieregge P., Graeber M.B. Role of mitochondria in Parkinson's disease. Biol. Chem. 380:1999;865-870.
148. Kranich O., Hamprecht B., Dringen R. Different preferences in the utilization of amino acids for glutathione synthesis in cultured neurons and astroglial cells derived from rat brain. Neurosci. Lett. 219:1996;211-214.
149. Kranich O., Dringen R., Sandberg M., Hamprecht B. Utilization of cysteine and cysteine precursors for the synthesis of glutathione in astroglial cultures: preference for cystine. Glia. 22:1998;11-18.
150. Kurz G.M., Wiesinger H., Hamprecht B. Purification of cytosolic malic enzyme from bovine brain, generation of monoclonal antibodies, and immunocytochemical localization of the enzyme in glial cells of neural primary cultures. J. Neurochem. 60:1993;1467-1474.
151. Kussmaul L., Hamprecht B., Dringen R. The detoxification of cumene hydroperoxide by the glutathione system of cultured astroglial cells hinges on hexose availability for the regeneration of NADPH. J. Neurochem. 73:1999;1246-1253.
152. Lada M.W., Kennedy R.T. In vivo monitoring of glutathione and cysteine in rat caudate nucleus using microdialysis on-line with capillary zone electrophoresis-laser induced fluorescence detection. J. Neurosci. Meth. 72:1997;153-159.
153. Langeveld C.H., Jongenelen C.A.M., Schepens E., Stoof J.C., Bast A., Drukarch B. Cultured rat striatal and cortical astrocytes protect mesencephalic dopaminergic neurons against hydrogen peroxide toxicity independent of their effect on neuronal development. Neurosci. Lett. 192:1995;13-16.
154. Langeveld C.H., Schepens E., Jongenelen C.A.M., Stoof J.C., Hjelle O.P., Ottersen O.P., Drukarch B. Presence of glutathione immunoreactivity in cultured neurons and astrocytes. Neuroreport. 7:1996;1833-1836.
155. Langston J.W., Ballard P., Tetrud J.W., Irwin I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science. 219:1983;979-980.
156. 35S ]glutathione binding sites in mouse and human spinal cord. J. Neurochem. 63:1994;155-160.
157. Lee W.J., Hawkins R.A., Peterson D.R., Vina J.R. Role of oxoproline in the regulation of neutral amino acid transport across the blood-brain barrier. J. Biol. Chem. 271:1996;19129-19133.
158. Lee T.K., Li L., Ballatori N. Hepatic glutathione and glutathione-S-conjugate transport mechanisms. Yale J. Biol. Med. 70:1997;287-300.
159. Li X., Orwar O., Revesjö C., Sandberg M. γ-Glutamyl peptides and related amino acids in rat hippocampus in vitro: effect of depolarization and γ-glutamyl transpeptidase inhibition. Neurochem. Int. 29:1996;121-128.
160. Li Y., Maher P., Schubert D. A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion. Neuron. 19:1997;453-463.
161. Li L., Lee T.K., Ballatori N. Functional re-evaluation of the putative glutathione transporters, RcGshT and RsGshT. Yale J. Biol. Med. 70:1997;301-310.
162. Li X., Wallin C., Weber S.G., Sandberg M. Net efflux of cysteine, glutathione and related metabolites from rat hippocampal slices during oxygen/glucose deprivation: dependence on γ-glutamyl transpeptidase. Brain Res. 815:1999;81-88.
163. Lindenau J., Noack H., Asayama K., Wolf G. Enhanced cellular glutathione peroxidase immunoreactivity in activated astrocytes and in microglia during excitotoxin induced neurodegeneration. Glia. 24:1998;252-256.
164. Liu D., Smith C.L., Barone F.C., Ellison J.A., Lysko P.G., Li K., Simpson I.A. Astrocytic demise precedes delayed neuronal death in focal ischemic rat brain. Mol. Brain Res. 68:1999;29-41.
165. Lopez-Barea J., Barcena J.A., Bocanegra J.A., Florindo J., Garcia-Alfonso C., Lopez-Ruiz A., Martinez-Galisteo E., Peinado J. Structure, mechanism, functions, and regulatory properties of glutathione reductase. Vina J. Glutathione: Metabolism and Physiological Functions. 1990;105-116 CRC Press, Boca Raton, FL, USA.
166. Love S. Oxidative stress in brain ischemia. Brain Pathol. 9:1999;119-131.
167. Lucas J.H., Wheeler D.G., Emery D.G., Mallery S.R. The endogenous antioxidant glutathione as a factor in the survival of physically injured mammalian spinal cord neurons. J. Neuropathol. Exp. Neurol. 57:1998;937-954.
168. Lucius R., Sievers J. Postnatal retinal ganglion cells in vitro: protection against reactive oxygen species (ROS)-induced axonal degeneration by cocultured astrocytes. Brain Res. 743:1996;56-62.
169. Makar T.K., Nedergaard M., Preuss A., Gelbard A.S., Perumal A.S., Cooper A.J.L. Vitamin E, ascorbate, glutathione, glutathione disulfide, and enzymes of glutathione metabolism in cultures of chick astrocytes and neurons: evidence that astrocytes play an important role in antioxidative processes in the brain. J. Neurochem. 62:1994;45-53.
170. Markesbery W.R., Carney J.M. Oxidative alterations in Alzheimer's disease. Brain Pathol. 9:1999;133-146.
171. Martinez M., Martinez N., Hernandez A.I., Ferrandiz M.L. Hypothesis: can N-acetylcysteine be beneficial in Parkinson's disease? Life Sci. 64:1999;1253-1257.
172. 2+ concentration, and neurotoxicity and increase antioxidant enzyme activities in hippocampal neurons. J. Neurochem. 65:1995;1740-1751.
173. Maybodi L., Pow D.V., Kharazia V.N., Weinberg R.J. Immunocytochemical demonstration of reduced glutathione in neurons of rat forebrain. Brain Res. 817:1999;199-205.
174. Meister A. Glutathione synthesis. Enzymes. 10:1974;671-697.
175. Meister A. Glutathione deficiency produced by inhibition of its synthesis, and its reversal; applications in research and therapy. Pharmacol. Ther. 51:1991;155-194.
176. Meister A. Glutathione-ascorbic acid antioxidant system in animals. J. Biol. Chem. 269:1994;9397-9400.
177. Meister A., Anderson M.E. Glutathione. Annu. Rev. Biochem. 52:1983;711-760.
178. Meister A., Tate S.S., Griffith O.W. γ-Glutamyl transpeptidase. Meth. Enzymol. 77:1981;237-253.
179. Mena M.A., Casarejos M.J., Carazo A., Paino C.L., de Yebenes J.G. Glia protect fetal midbrain dopamine neurons in culture from L-DOPA toxicity through multiple mechanisms. J. Neural Transm. 104:1997;317-328.
180. Mesina J.E., Page R.H., Hetzel F.W., Chopp M. Administration of L-2-oxothiazolidine-4-carboxylate increases glutathione levels in rat brain. Brain Res. 478:1989;181-183.
181. Minghetti L., Levi G. Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide. Prog. Neurobiol. 54:1998;99-125.
182. Mischel R.E., Kim Y.S., Sheldon R.A., Ferriero D.M. Hydrogen peroxide is selectively toxic to immature murine neurons in vitro. Neurosci. Lett. 231:1997;17-20.
183. Misra I., Griffith O.W. Expression and purification of human γ-glutamylcysteine synthetase. Prot. Expr. Purific. 13:1998;268-276.
184. Mizui T., Kinouchi H., Chan P.H. Depletion of brain glutathione by buthionine sulfoximine enhances cerebral ischemic injury in rats. Am. J. Physiol. 262:1992;H313-H317.
185. Mizuno Y., Yoshino H., Ikebe S., Hattori N., Kobayashi T., Shimoda-Matsubayashi S., Matsumine H., Kondo T. Mitochondrial dysfunction in Parkinson's disease. Ann. Neurol. 44:(1):1998;S99-S109.
186. Mo J.Q., Hom D.G., Andersen J.K. Decrease in protective enzymes correlates with increased oxidative damage in the aging mouse brain. Mech. Ageing Dev. 81:1995;73-82.
187. Montoliu C., Sancho-Tello M., Azorin I., Burgal M., Valles S., Renau-Piqueras J., Guerri C. Ethanol increases cytochrome P450E1 and induces oxidative stress in astrocytes. J. Neurochem. 65:1995;2561-2570.
188. Müller W.E.G., Romero F.J., Perovic S., Pergande G., Pialoglou P. Protection of flupirtine on β-amyloid-induced apoptosis in neuronal cells in vitro: prevention of amyloid-induced glutathione depletion. J. Neurochem. 68:1997;2371-2377.
189. Mytilineou C., Kokotos Leonardi E.T., Kramer B.C., Jamindar T., Olanow C.W. Glial cells mediate toxicity in glutathione-depleted mesencephalic cultures. J. Neurochem. 73:1999;112-119.
190. Nakamura K., Wang W., Kang U.J. The role of glutathione in dopaminergic neuronal survival. J. Neurochem. 69:1997;1850-1858.
191. Nicklas W.J., Vyas I., Heikkila R.E. Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenylpyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. Life Sci. 36:1985;2503-2508.
192. Noack, H., Possel, H., Rethfeldt, C., Keilhoff, G., Wolf, G., 1999. Peroxynitrite mediated damage and lowered superoxide tolerance in primary cortical glial cultures after induction of the inducible isoform of NOS. Glia 28, 13-24.
193. Noble P.G., Antel J.P., Yong V.W. Astrocytes and catalase prevent the toxicity of catecholamines to oligodendrocytes. Brain Res. 633:1994;83-90.
194. Noel F., Tofilon P.J. Astrocytes protect against X-ray-induced neuronal toxicity in vitro. Neuroreport. 9:1998;1133-1137.
195. O'Connor E., Devesa A., Garcia C., Puertes I.R., Pellin A., Vina J.R. Biosynthesis and maintenance of GSH in primary astrocyte cultures: role of cystine and ascorbate. Brain Res. 680:1995;157-163.
196. Ogita K., Enomoto R., Nakahara F., Ishitsubo N., Yoneda Y. A possible role of glutathione as an endogenous agonist at the N-methyl-D-aspartate recognition domain in rat brain. J. Neurochem. 64:1995;1088-1096.
197. Okonkwo P.O., Orlowski M., Green J.P. Enzymes of the γ-glutamyl cycle in the choroid plexus and brain. J. Neurochem. 22:1974;1053-1058.
198. Olney J.W., Zorumsky C., Price M.T., Labruyere J. L-Cysteine, a bicarbonate-sensitive endogenous excitotoxin. Science. 243:1990;596-599.
199. Oppenheimer L., Wellner V.P., Griffith O.W., Meister A. Glutathione synthetase: purification from rat kidney and mapping of substrate binding sites. J. Biol. Chem. 254:1979;5184-5190.
200. Orlowski M., Sessa G., Green J.P. γ-Glutamyl transpeptidase in brain capillaries: possible site of a blood-brain barrier for amino acids. Science. 184:1974;66-68.
201. Orwar O., Li X., Andine P., Bergström C.-M., Hagberg H., Folestad S., Sandberg M. Increased intra- and extra-cellular concentration of γ-glutamylglutamate and related dipeptides in the ischemic rat striatum: involvement of γ-glutamyl transpeptidase. J. Neurochem. 63:1994;1371-1376.
202. Oyama Y., Sadakata C., Chikahisa L., Nagano T., Okazaki E. Flow-cytometric analysis on kainate-induced decrease in the cellular content of non-protein thiols in dissociated rat brain neurons. Brain. Res. 760:1997;277-280.
203. 4. J. Pharmacol. Exp. Ther. 219:1981;91-96.
204. Pan Z., Perez-Polo R. Role of nerve growth factor in oxidant homeostasis: glutathione metabolism. J. Neurochem. 61:1993;1713-1721.
205. Pan Z., Perez-Polo R. Regulation of γ-glutamylcysteine synthetase activity by nerve growth factor. Int. J. Dev. Neurosci. 14:1996;559-566.
206. Papadopoulos M.C., Koumenis I.L., Dugan L.L., Giffard R.G. Vulnerability to glucose deprivation injury correlates with glutathione levels in astrocytes. Brain Res. 748:1997;151-156.
207. Papadopoulos M.C., Koumenis I.L., Yuan T.Y., Giffard R.G. Increasing vulnerability of astrocytes to oxidative injury with age despite constant antioxidant defenses. Neuroscience. 82:1998;915-925.
208. Pearce R.K.B., Owen A., Daniel S., Jenner P., Marsden C.D. Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease. J. Neural Transm. 104:1997;661-677.
209. Peuchen S., Duchen M.R., Clark J.B. Modulation of the glutathione redox state in adult astrocytes. Biochem. Soc. Trans. 24:1996;449S.
210. Peuchen S., Bolanos J.P., Heales S.J.R., Almeida A., Duchen M.R., Clark J.B. Interrelationships between astrocyte function, oxidative stress and antioxidant status within the central nervous system. Prog. Neurobiol. 52:1997;261-281.
211. Philbert M.A., Beiswanger C.M., Waters D.K., Reuhl K.R., Lowndes H.E. Cellular and regional distribution of reduced glutathione in the nervous system of the rat: histochemical localization by mercury orange and o-phthaldialdehyde-induced histofluorescence. Toxicol. Appl. Pharmacol. 107:1991;215-227.
212. Philbert M.A., Beiswanger C.M., Manson M.M., Green J.A., Novak R.F., Primiano T., Reuhl K.R., Lowndes H.E. Glutathione-S-transferases and γ-glutamyl transpeptidase in the rat nervous system: a basis for differential susceptibility to neurotoxicants. Neurotoxicology. 16:1995;349-362.
213. Pileblad E., Magnusson T. Increase in rat brain glutathione following intracerebroventricular administration of γ-glutamylcysteine. Biochem. Pharmacol. 44:1992;895-903.
214. Pileblad E., Magnuson T., Fornstedt B. Reduction of brain glutathione by L-buthionine sulfoximine potentiates the dopamine-depletion action of 6-hydroxydopamine in rat striatum. J. Neurochem. 52:1989;978-980.
215. Pileblad E., Eriksson P.S., Hansson E. The presence of glutathione in primary neuronal and astroglial cultures from rat cerebral cortex and brain stem. J. Neural Transm. 86:1991;43-49.
216. Poot M., Teubert H., Rabinovitch P.S., Kavanagh T.J. De novo synthesis of glutathione is required for both entry into and progression through the cell cycle. J. Cell. Physiol. 163:1995;555-560.
217. Porter N.A. Chemistry of lipid peroxidation. Meth. Enzymol. 105:1984;273-282.
218. Puka-Sundvall M., Eriksson P., Nilsson M., Sandberg M., Lehmann A. Neurotoxicity of cysteine: interaction with glutamate. Brain Res. 705:1995;65-70.
219. Radi R., Castro L., Rodriguez M., Cassina A., Thomson L. Free radical damage to mitochondria. Beal M.F., Howell N., Bodis-Wollner I. Mitochondria and Free Radicals in Neurodegenerative Diseases. 1997;57-89 Wiley-Liss, New York.
220. Raps S.P., Lai J.C.K., Hertz L., Cooper A.J.L. Glutathione is present in high concentrations in cultured astrocytes but not in cultured neurons. Brain Res. 493:1989;398-401.
221. Ratan R.R., Murphy T.H., Baraban J.M. Macromolecular synthesis inhibitors prevent oxidative stress-induced apoptosis in embryonic cortical neurons by shunting cysteine from protein synthesis to glutathione. J. Neurosci. 14:1994;4385-4392.
222. Regan R.F., Guo Y. Extracellular reduced glutathione increases neuronal vulnerability to combined chemical hypoxia and glucose deprivation. Brain Res. 817:1999;145-150.
223. Regan R.F., Guo Y. Potentiation of excitotoxic injury by high concentrations of extracellular reduced glutathione. Neuroscience. 91:1999;463-470.
224. Reichelt K.L. The isolation of gamma-glutamyl peptides from monkey brain. J. Neurochem. 17:1970;19-25.
225. Reiter R.J. Oxidative damage in the central nervous system: protection by melatonin. Prog. Neurobiol. 56:1998;359-384.
226. Retz W., Gsell W., Münch G., Rösler M., Riederer P. Free radicals in Alzheimer's disease. J. Neural Transm. 54:1998;221-236.
227. Reyes E., Barela T.D. Isolation and purification of multiple forms of γ-glutamyl transpeptidase from rat brain. Neurochem. Res. 5:1980;159-170.
228. Rice M.E., Russo-Menna I. Differential compartimentalization of brain ascorbate and glutathione between neurons and glia. Neuroscience. 82:1998;1213-1223.
229. Richman P.G., Meister A. Regulation of γ-glutamylcysteine synthetase by nonallosteric feedback inhibition by glutathione. J. Biol. Chem. 250:1975;1422-1426.
230. Richter-Landsberg C., Vollgraf U. Mode of cell injury and death after hydrogen peroxide exposure in cultured oligodendroglial cells. Exp. Cell Res. 244:1998;218-229.
231. Riederer P., Sofic E., Rausch W.D., Schmidt B., Reynolds G.P., Jellinger K., Youdim M.B.H. Transition metals, ferritin, glutathione and ascorbic acid in Parkinsonian brain. J. Neurochem. 52:1989;515-520.
232. Robberecht W., van den Bosch L. The pathogenesis of amyotrophic lateral sclerosis. Neurosci. Res. Commun. 23:1998;67-75.
233. Robinson S.R., Schousboe A., Dringen R., Magistretti P., Coles J., Hertz L. Metabolic trafficking between neurons and glia. Laming P.R., Sykova E., Reichenbach A., Hatton G.I., Bauer H. Glial Cells: Their Role in Behaviour. 1998;83-106 Cambridge University Press, Cambridge, UK.
234. Rosenberg P.A., Li Y., Ali S., Altiok N., Back S.A., Volpe J.J. Intracellular redox state determines whether nitric oxide is toxic or protective to rat oligodendrocytes in culture. J. Neurochem. 73:1999;476-484.
235. Saez G.T., Bannister W.H., Bannister J.V. Free radicals and thiol compounds - the role of glutathione against free radical toxicity. Vina J. Glutathione: Metabolism and Physiological Functions. 1990;237-254 CRC Press, Boca Raton, FL, USA.
236. Sagara Y. Induction of reactive oxygen species in neurons by haloperidol. J. Neurochem. 71:1998;1002-1012.
237. Sagara J., Miura K., Bannai S. Maintenance of neuronal glutathione by glial cells. J. Neurochem. 61:1993;1672-1676.
238. Sagara J., Makino N., Bannai S. Glutathione efflux from cultured astrocytes. J. Neurochem. 66:1996;1876-1881.
239. Salinas A.E., Wong M.G. Glutathione S-transferases - a review. Curr. Med. Chem. 6:1999;279-309.
240. Sandberg M., Li X., Folestad S., Weber S.G., Orwar O. Liquid chromatographic determination of acidic β-aspartyl and γ-glutamyl peptides in extracts of rat brain. Anal. Biochem. 217:1994;48-61.
241. Sankarapandi S., Zweier J.L., Mukherjee G., Quinn M.T., Huso D.L. Measurement and characterization of superoxide generation in microglial cells: evidence for an NADPH oxidase-dependent pathway. Arch. Biochem. Biophys. 353:1998;312-321.
242. Schapira A.H.V., Cooper J.M., Dexter D., Clark J.B., Jenner P., Marsden C.D. Mitochondrial complex I deficiency in Parkinson's disease. J. Neurochem. 54:1990;823-827.
243. Schirmer R.H., Krauth-Siegel R.L., Schulz G.E. Glutathione reductase. Dolphin D., Poulson R., Avramovic O. Glutathione: Chemical, Biochemical and Medical Aspects - Part A. 1989;553-596 Wiley, New York.
244. Schroeter M.L., Mertsch K., Giese H., Müller S., Sporbert A., Hickel B., Blasig I.E. Astrocytes enhance radical defence in capillary endothelial cells constituting the blood-brain barrier. FEBS Lett. 449:1999;241-244.
245. Schütte M., Werner P. Redistribution of glutathione in the ischemic rat retina. Neurosci. Lett. 246:1998;53-56.
246. Sekura R., Meister A. γ-Glutamylcysteine synthetase: further purification, 'half of the sites' reactivity, subunits, and specificity. J. Biol. Chem. 252:1977;2599-2605.
247. Selak I., Skaper S.D., Varon S. Pyruvate participation in the low molecular weight trophic activity for central nervous system neurons in glia-conditioned media. J. Neurosci. 5:1985;23-28.
248. Seyfried J., Soldner F., Schulz J.B., Klockgether T., Kovar K.A., Wüllner U. Differential effects of L-buthionine sulfoximine and ethacrynic acid on glutathione levels and mitochondrial function in PC12 cells. Neurosci. Lett. 264:1999;1-4.
249. Shaw C.A., Pasqualotto B.A., Curry K. Glutathione-induced sodium currents in neocortex. Neuroreport. 7:1996;1149-1152.
250. Shine H.D., Haber B. Immunocytochemical localization of γ-glutamyl transpeptidase in the rat CNS. Brain Res. 217:1981;339-349.
251. Sian J., Dexter D.T., Lees A.J., Daniel S., Agid Y., Javoy-Agid F., Jenner P., Marsden C.D. Alterations in glutathion levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann. Neurol. 36:1994;348-355.
252. Sian J., Dexter D.T., Lees A.J., Daniel S., Jenner P., Marsden C.D. Glutathione-related enzymes in brain in Parkinson's disease. Ann. Neurol. 36:1994;356-361.
253. Sies H. Oxidative Stress: Oxidants and Antioxidants. 1991;Academic Press, New York.
254. Singh S.P., Wishnok J.S., Keshive M., Deen W.M., Tannenbaum S.R. The chemistry of the S-nitrosoglutathione/glutathione system. Proc. Natl. Acad. Sci. USA. 93:1996;14428-14433.
255. Skaper S.D., Walsh F.S. Neurotrophic molecules: strategies for designing effective therapeutic molecules in neurodegeneration. Mol. Cell. Neurosci. 12:1998;179-193.
256. Slivka A., Mytilineou C., Cohen G. Histochemical evaluation of glutathione in brain. Brain Res. 409:1987;273-284.
257. Smythies J.R. Oxidative reactions and Schizophrenia: a review-discussion. Schizophrenia Res. 24:1997;357-364.
258. Sofic E., Paulus W., Jellinger K., Riederer P., Youdim M.B.H. Selective increase of iron in substantia nigra zona compacta of parkinsonian brains. J. Neurochem. 56:1991;978-982.
259. Sofic E., Lange K.W., Jellinger K., Riederer P. Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease. Neurosci. Lett. 142:1992;128-130.
260. Spina M.B., Squinto S.P., Miller J., Lindsay R.M., Hyman C. Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: involvement of the glutathione system. J. Neurochem. 59:1992;99-106.
261. Sun A.Y., Chen Y.-M. Oxidative stress and neurodegenerative disorders. J. Biomed. Sci. 5:1998;401-414.
262. Takizawa S., Matsushima K., Shinohara Y., Ogawa S., Komatsu N., Utsunomiya H., Watanabe K. Immunohistochemical localization of glutathione peroxidase in infarcted human brain. J. Neurol. Sci. 122:1994;66-73.
263. Tamura T., McMicken H.W., Smith C.V., Hansen T.N. Gene structure for mouse glutathione reductase, including a putative mitochondrial targeting signal. Biochem. Biophys. Res. Commun. 237:1997;419-422.
264. Taniguchi N., Ikeda Y. γ-Glutamyl transpeptidase: catalytic mechanism and gene expression. Adv. Enzymol. 72:1998;239-278.
265. Tansey F.A., Cammer W. A Pi form of glutathione-S-transferase is a myelin- and oligodendrocyte-associated enzyme in mouse brain. J. Neurochem. 57:1991;95-102.
266. Tate S.S., Ross L.L., Meister A. The γ-glutamyl cycle in the choiroid plexus: its possible function in amino acid transport. Proc. Natl. Acad. Sci. USA. 70:1973;1447-1449.
267. Tate S.S. Microvillus membrane peptidases that catalyze hydrolysis of cysteinylglycine and its derivatives. Meth. Enzymol. 113:1985;471-484.
268. Thompson G.A., Meister A. Utilization of L-cystine by the γ-glutamyl transpeptidase - γ-glutamyl cyclotransferase pathway. Proc. Natl. Acad. Sci. USA. 72:1975;1985-1988.
269. Thornburne S.K., Juurlink B.H.J. Low glutathione and high iron govern the susceptibility of oligodendroglial precursors to oxidative stress. J. Neurochem. 67:1996;1014-1022.
270. Toffa S., Kunikowska G.M., Zeng B.Y., Jenner P., Marsden C.D. Glutathione depletion in rat brain does not cause nigrostriatal pathway degeneration. J. Neural Transm. 104:1997;67-75.
271. ε-AMCA in astrocytes. Glia. 25:1999;10-20.
272. Trepanier G., Furling D., Puymirat J., Mirault M.E. Immunocytochemical localization of seleno-glutathione peroxidase in the adult mouse brain. Neuroscience. 75:1996;231-243.
273. Tsacopoulos M., Magistretti P.J. Metabolic coupling between glia and neurons. J. Neurosci. 16:1996;877-885.
274. Tutic M., Lu X., Schirmer R.H., Werner D. Cloning and sequencing of mammalian glutathione reductase cDNA. Eur. J. Biochem. 188:1990;523-528.
275. Ursini F., Maiorino M., Brigelius-Flohe' R., Aumann K.D., Roveri A., Schomburg D., Flohe' L. Diversity of glutathione peroxidases. Meth. Enzymol. 252:1995;38-53.
276. Ushijima K., Miyazaki H., Morioka T. Immunohistochemical localization of glutathione peroxidase in the brain of the rat. Resuscitation. 13:1986;97-105.
277. van den Dobbelsteen D.J., Nobel C.S.I., Schlegel J., Cotgreave I.A., Orrenius S., Slater A.F. Rapid and specific efflux of reduced glutathione during apoptosis induced by anti-Fas/APO-1 antibody. J. Biol. Chem. 271:1996;15420-15427.
278. Varga V., Janaky R., Saransaari P., Oja S.S. Endogenous γ-L-glutamyl and β-L-aspartyl peptides and excitatory aminoacidergic neurotransmission in the brain. Neuropeptides. 27:1994;19-26.
279. Varga V., Jenei Z., Janaky R., Saransaari P., Oja S.S. Glutathione is an endogenous ligand of rat brain N-methyl-D-aspartate (NMDA) and 2-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptors. Neurochem. Res. 22:1997;1165-1171.
280. Vernet P., Rigaudiere N., Ghyselinck N., Dufaure J.P., Drevet J.R. In vitro expression of a mouse tissue specific glutathione-peroxidase-like protein lacking the selenocysteine can protect stably transfected mammalian cells against oxidative damage. Biochem. Cell Biol. 74:1996;125-131.
281. Vina J.R., Palacin M., Puertes I.R., Hernandez R., Vina J. Role of γ-glutamyl cycle in the regulation of amino acid translocation. Am. J. Physiol. 257:1989;E916-E922.
282. Wade L.A., Brady H.M. Cysteine and cystine transport at the blood-brain barrier. J. Neurochem. 37:1981;730-734.
283. Wardman P., Candeias L.P. Fenton chemistry: an introduction. Radiat. Res. 145:1996;523-531.
284. White A.R., Bush A.I., Beyreuther K., Masters C.L., Cappai R. Exacerbation of copper toxicity in primary neuronal cultures depleted of cellular glutathione. J. Neurochem. 72:1999;2092-2098.
285. Whittemore E.R., Loo D.T., Watt J.A., Cotman C.W. A detailed analysis of hydrogen peroxide-induced cell death in primary neuronal cultures. Neuroscience. 67:1995;921-932.
286. Wiesinger H., Hamprecht B., Dringen R. Metabolic pathways for glucose in astrocytes. Glia. 21:1997;22-34.
287. Williams L.R. Oxidative stress, age-related neurodegeneration, and the potential for neurotrophic treatment. Cerebrovasc. Brain Metab. Rev. 7:1995;55-73.
288. Wilson J.X. Antioxidant defense of the brain: a role for astrocytes. Can. J. Physiol. Pharmacol. 75:1997;1149-1163.
289. Winkler B.S., Orselli S.M., Rex T.S. The redox couple between glutathione and ascorbic acid: a chemical and physiological perspective. Free Radical Biol. Med. 17:1994;333-349.
290. Winterbourn C.C. Toxicity of iron and hydrogen peroxide: the Fenton reaction. Toxicol. Lett. 82/83:1995;969-974.
291. Winterbourn C.C., Metodiewa D. The reactions of superoxide with reduced glutathione. Arch. Biochem. Biophys. 314:1994;284-290.
292. Wolf R., Wolf D., Ruocco V. Vitamine E: the radical protector. J. Eur. Acad. Dermatol. Venerol. 10:1998;103-117.
293. Wolff J.E.A., Munstermann G., Grebenkämper K., Erben M. Gamma-glutamyl transpeptidase does not act as a cystine transporter in brain microvessels. Neurochem. Res. 23:1998;1175-1178.
294. + toxicity in nigral dopaminergic neurons. Neuroreport. 7:1996;921-923.
295. Wüllner U., Seyfried J., Groscurth P., Beinroth S., Winter S., Gleichmann M., Heneka M., Löschmann P.A., Schulz J.B., Weller M., Klockgether T. Glutathione depletion and neuronal cell death: the role of reactive oxygen intermediates and mitochondrial function. Brain Res. 826:1999;53-62.
296. Yang C.S., Chou S.T., Lin N.N., Liu L., Tsai P.J., Kuo J.S., Lai J.S. Determination of extracellular glutathione in rat brain by microdialysis and high-performance liquid chromatography with fluorescence detection. J. Chromatogr. B Biomed. Appl. 661:1994;231-235.
297. Yonezawa M., Back S.A., Gan X., Rosenberg P.A., Volpe J.J. Cystine deprivation induces oligodendroglial death: rescue by free radical scavangers and by a diffusible glial factor. J. Neurochem. 67:1996;566-573.
298. Yu B.P. Cellular defenses against damage from reactive oxygen species. Physiolog. Rev. 74:1994;139-162.
299. 15N ]glutamate. J. Neurochem. 55:1990;137-145.
300. Zängerle L., Cuenod M., Winterhalter K.H., Do K.Q. Screening of thiol compounds: depolarization-induced release of glutathione and cysteine from rat brain slices. J. Neurochem. 59:1992;181-189.
301. Zeevalk G.D., Bernard L.P., Albers D.S., Mirochnitchenko O., Nicklas W.J., Sonsalla P.K. Energy stress-induced dopamine loss in glutathione peroxidase-overexpressing transgenic mice and in glutathione-depleted mesencephalic cultures. J. Neurochem. 68:1997;426-429.
302. Zeevalk G.D., Bernard L.P., Sinha C., Ehrhart J., Nicklas W.J. Excitotoxicity and oxidative stress during inhibition of energy metabolism. Dev. Neurosci. 20:1998;444-453.
303. Zlokovic B.V., Mackic J.B., McComb J.G., Weiss M.H., Kaplowitz N., Kannan R. Evidence for transcapillary transport of reduced glutathione in vascular perfused guinea-pig brain. Biochem. Biophys Res. Commun. 201:1994;402-408.